Ajanta Pharma Q3 Profit Up 11% to Rs 233 cr
Ajanta Pharma's consolidated profit after tax for Q3 FY25 rose 11% YoY to Rs 233 crore, driven by increased revenue. The company's shares closed 1.64% higher on BSE.
New Delhi, Jan 30 (PTI) Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the third quarter ended December 31, 2024.
The drug firm had reported a profit after tax (PAT) of Rs 210 crore in the October-December period of last fiscal.
Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.
Shares of the company settled 1.64 per cent higher at Rs 2,670.70 apiece on the BSE.
The drug firm had reported a profit after tax (PAT) of Rs 210 crore in the October-December period of last fiscal.
Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.
Shares of the company settled 1.64 per cent higher at Rs 2,670.70 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.04 ( -1.68)
- 102363129
- Srestha Finvest
- 0.51 ( -3.77)
- 22605309
- GMR Airports
- 76.30 (+ 0.83)
- 19768792
- Bajaj HindusthanSuga
- 19.57 ( -2.59)
- 15088109
- G G Engineering
- 0.90 ( -3.23)
- 13176176
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback